502.
Juliet I Mmerem, Chukwudi C Umenzekwe, Mafuka S Johnson et al.,
Mpox and Chickenpox Co-infection: Case Series from Southern Nigeria, 2023.12.07,
https://doi.org/10.1093/infdis/jiad556 .
This study describes clinico-epidemiologic characteristics of mpox∕chickenpox co-infection in Nigeria.
501.
Lisa J Speiser, Alex M Wonnaparhown, Janis Blair et al.,
A Case of Sustained Viral Shedding of Mpox with Ocular Involvement Resulting in Vision Loss, 2023.12.14,
https://doi.org/10.1093/ofid/ofad632 .
This study describes a patient with advanced human immunodeficiency virus (HIV) infection and sustained viral shedding of mpox with ocular involvement, which resulted in vision loss.
500.
Ke-jia Shan, Changcheng Wu, Xiaolu Tang et al.,
Molecular Evolution of Protein Sequences and Codon Usage in Monkeypox Viruses, 2023.12.12,
https://doi.org/10.1093/gpbjnl/qzad003 .
This study sheds new light on the mechanisms that govern the evolution of MPXV in human populations.
499.
Mary K Hayden, Kimberly E Hanson, Janet A Englund et al.,
He Infectious Diseases Society of America Guidelines on the Diagnosis of Coronavirus Disease 2019 (COVID-19): Molecular Diagnostic Testing, 2023.12.19,
https://doi.org/10.1093/cid/ciad646 .
This article provides a conceptual framework for understanding molecular diagnostic test performance, discuss nuances of test result interpretation in a variety of practice settings, and highlight important unmet research needs related to COVID-19 diagnostic testing.
498.
Annette K Regan, Onyebuchi A Arah, Deshayne B Fell et al.,
Annette K Regan, Onyebuchi A Arah, Deshayne B Fell, 2023.12.07,
https://doi.org/10.1093/ofid/ofad613 .
This article conducted a national cohort study of 93,624 deliveries occurring between 11 March 2020 and 1 July 2021 using medical claims information from the OptumLabs® Data Warehouse.
497.
David A Weaver,
The Mortality Experience of Disabled Persons in the United States During the COVID-19 Pandemic, 2023.12.08,
https://doi.org/10.1093/haschl/qxad082 .
This study argues that future public information campaigns about vaccines and other measures may be more successful if they include specific efforts to directly target disability beneficiaries. In addition, clinical trials and other research should consider including disabled persons as specific study groups as the severity of their underlying health impairments is likely comparable to that of persons of advanced age.
496.
Kyungmin Huh, Minsun Kang, Young-Eun Kim et al.,
Risk of Severe COVID-19 and Protective Effectiveness of Vaccination Among Solid Organ Transplant Recipients, 2023.12.14,
https://doi.org/10.1093/infdis/jiad501 .
This study argues that vaccination is effective in preventing the progression to severe COVID-19. Efforts should be made to improve vaccine uptake among SOTRs, while additional protective measures should be developed.
495.
Makenzie E Mabry, Angela Fanelli, Carla Mavian et al.,
The panzootic potential of SARS-CoV-2, 2023.12.18,
https://doi.org/10.1093/biosci/biad102 .
This study argues that the use of the term panzootic could be a more appropriate term than pandemic to describe the ongoing scenario.
494.
Michael Wong, Chandrima Gain, Madhav B Sharma, et al.,
Severe Acute Respiratory Syndrome Coronavirus 2 Infection Alters Mediators of Lung Tissue Remodeling In Vitro and In Vivo, 2023.12.18,
https://doi.org/10.1093/infdis/jiad536 .
This article provides novel mechanistic insight that the differential impact of SARS-CoV-2 variants on severity of COVID-19 may partially be attributed to unique changes in MMPs.
493.
Marie-Claude Blatter, Monique Zahn-Zabal, Samuel Moix et al.,
Bringing Science to the Public in the Light of Evolution, 2023.12.18,
https://doi.org/10.1093/biomethods/bpad040 .
This article aims to create stories and activities that resonate with participants, offering a tangible and enjoyable experience. By providing opportunities that reflect real-world scientific practices, this article seeks to offer participants valuable insights into the current workings of scientists ′in the light of evolution.′
Beijing Interest Group on Global Health and Global Governance
Contact: secretary@bigghgg.cn